It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nanocomplexes systems made up natural poylymers have pharmacotechnical advantages such as increase of water solubility and a decrease of drugs toxicity. Amphotericin B (AmB) is a drug apply as anti-leishmanial and anti-fungal, however it has low water solubility and high toxicity, limiting its therapeutic application. With this in mind, the present study aimed to produce nanocomplexes composed by alginate (Alg), a natural polymer, with AmB covered by nanocrystals from bacterial cellulose (CNC). For this reason, the nanocomplexes were produced utilizing sodium alginate, amphotericin B in a borate buffer (pH 11.0). The CNC was obtained by enzymatic hydrolysis of the bacterial cellulose. To CNC cover the nanocomplexes 1 ml of the nanocomplexes was added into 1 ml of 0.01% CNC suspension. The results showed an ionic adsorption of the CNC into the Alg-AmB nanocomplexes surface. This phenomena was confirmed by an increase in the particle size and PDI decrease. Besides, nanocomplexes samples covered by CNC showed uniformity. The amorphous inclusion of AmB complex into the polysaccharide chain network in both formulations. AmB in the nanocomplexes was in supper-aggregated form and showed good biocompatibility, being significantly less cytotoxic in vitro against kidney cells and significantly less hemolytic compared to the free-drug. The in vitro toxicity results indicated the Alg-AmB nanocomplexes can be considered a non-toxic alternative to improve the AmB therapeutic effect. All process to obtain nanocomplexes and it coat was conduce without organic solvents, can be considered a green process, and allowed to obtain water soluble particles. Furthermore, CNC covering the nanocomplexes brought additional protection to the system can contribut advancement in the pharmaceutical.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Sorocaba, LAMINFE – Laboratory of Industrial Microbiology and Fermentation Process, Sorocaba, Brazil (GRID:grid.442238.b) (ISNI:0000 0001 1882 0259); University of Minho, CEB - Centre of Biological Engineering, Braga, Portugal (GRID:grid.10328.38) (ISNI:0000 0001 2159 175X)
2 University of Minho, CEB - Centre of Biological Engineering, Braga, Portugal (GRID:grid.10328.38) (ISNI:0000 0001 2159 175X)
3 University of Minho, CEB - Centre of Biological Engineering, Braga, Portugal (GRID:grid.10328.38) (ISNI:0000 0001 2159 175X); University of Minho, Centre of Chemistry, Braga, Portugal (GRID:grid.10328.38) (ISNI:0000 0001 2159 175X)
4 University of Sorocaba, Lapetox – Laboratory of Toxicology Research, Sorocaba, Brazil (GRID:grid.442238.b) (ISNI:0000 0001 1882 0259)
5 University of Sorocaba, LABNUS – Biomaterials and Nanotechnology Laboratory, Sorocaba, Brazil (GRID:grid.442238.b) (ISNI:0000 0001 1882 0259)
6 University of Sorocaba, LAMINFE – Laboratory of Industrial Microbiology and Fermentation Process, Sorocaba, Brazil (GRID:grid.442238.b) (ISNI:0000 0001 1882 0259)